13G Filing: Highbridge Capital Management and Novelion Therapeutics Inc. (NVLN)

Page 6 of 6

Page 6 of 6 – SEC Filing

SIGNATURES

After reasonable
inquiry and to the best of our knowledge and belief, the undersigned certifies that the information set forth in this statement
is true, complete and correct.

DATED: May 1, 2017

HIGHBRIDGE CAPITAL MANAGEMENT, LLC
By:

/s/ John Oliva

Name: John Oliva
Title: Managing Director

Follow Novelion Therapeutics Inc. (NASDAQ:NVLN)

Page 6 of 6